Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports | Zendy

Mian Bilal Alam | Zendy; Muhammad Bilal Munir | Zendy; Rishi Rattan | Zendy; Evan Adelstein | Zendy; Sandeep Jain | Zendy; Samir Saba | Zendy

Open Access

Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports

Author(s) -

Mian Bilal Alam,

Muhammad Bilal Munir,

Rishi Rattan,

Evan Adelstein,

Sandeep Jain,

Samir Saba

Publication year - 2016

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/euw044

Subject(s) - medicine , cardiac resynchronization therapy , battery (electricity) , cohort , longevity , cardiology , heart failure , emergency medicine , gerontology , power (physics) , physics , ejection fraction , quantum mechanics

Cardiac resynchronization therapy (CRT) is an important treatment for heart failure that requires constant ventricular pacing, placing a high energy burden on CRT defibrillators (CRT-D). Longer battery life reduces the need for device changes and associated complications, thereby affecting patient outcomes and cost of care. We therefore investigated the time to battery depletion of CRT-D from different manufacturers and compared these results with manufacturers' published product performance reports (PPRs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research